Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Which questions remain unanswered following the successful development of sorafenib in hepatocellular carcinoma?

Which questions remain unanswered following the successful development of sorafenib in hepatocellular carcinoma? Nat Clin Pract Oncol. 2009 Feb; 6(2):64-5.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.